Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJsc Halyk Reg S Regulatory News (HSBK)

Share Price Information for Jsc Halyk Reg S (HSBK)

Share Price is delayed by 15 minutes
Get Live Data
31.00    0.05 (0.16%)
Bid:
31.00
Ask:
31.10
Spread: 0.10 (0.323%)
Market Cap: $8.44b
HSBK Live PriceLast checked at - London Stock Exchange

Intraday Jsc Halyk Reg S Share Chart

  • This share is an international stock.

Stabilisation Notice

14 Dec 2006 08:18

Credit Suisse Securities (Eur) Ltd14 December 2006 Not for distribution, directly or indirectly, in or into the United States orany jurisdiction in which such distribution would be unlawful. 14th December 2006 JSC Halyk Savings Bank of Kazakhstan: Base offering of42,500,000 GDR's Stabilisation Notice Pursuant to Core Dealing Rule 3060-3061, Credit Suisse Securities (Europe)Limited hereby notifies the London Stock Exchange that it and its affiliates maystabilise the offering of JSC Halyk Savings Bank of Kazakhstan Securities to bestabilised are: JSC Halyk Savings Bank of Kazakhstan GDR's RegS (US46627J3023) 1. Stabilising Manager: Credit Suisse Securities (Europe) Limited (a memberfirm). Contacts - Tom Ahearne 0207 888 3818; Nicolas Meer 020 888 7178;Indranil Bhattacharyya 0207 888 2057 2. Stabilisation period commences: Thursday 14th December 2006 at 09.00amLondon time. 3. Stabilisation period ends: upon notification on or before close ofbusiness on Friday 12th January 2007; 4. Offer price: 16.00 USD for GDRs 5. Over-allotment is up to 10% of deal size - 4,250,000 GDRs ** ** Note that the over-allotment will be structured as a reverse greenshoe; theunderwriters will buy the over-allotment GDRs from an existing shareholder andbe granted a put option to sell back to that shareholder should stabilisation inthe market be required. For the avoidance of doubt stabilisation funds will beavailable to the underwriters due to deferred settlement of the initial purchaseof the over-allotment shares. This announcement is for information purposes only and does not constitute aninvitation or offer to underwrite, subscribe for or otherwise acquire or disposeof any securities of the Issuer in any jurisdiction. This material was produced by Credit Suisse Securities (Europe) Limited, a firmregulated and authorised by The Financial Services Authority (the "FSA") and isnot for distribution to private customers, as defined by the rules of the FSA orto be used or considered as an offer to sell or solicitation of an offer to buyany securities. This announcement is not an offer of securities for sale into the United States.The securities have not been, and will not be, registered under the UnitedStates Securities Act of 1933 and may not be offered or sold in the UnitedStates absent registration or an exemption from registration. There will be nopublic offer of securities in the United States. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Sep 20247:26 amRNSMoodys upgrades ratings at the sovereign - Baa1
23rd Aug 202412:36 pmRNSChanges to the Management Board
19th Aug 20248:50 amRNS1H and 2Q 2024 financial results
13th Aug 20241:25 pmRNS1H & 2Q 2024 Results (the date has been changed )
6th Aug 20241:12 pmRNS1H & 2Q 2024 Results
2nd Aug 20244:39 pmRNSSustainability Report 2023
17th May 20249:59 amRNS1st Quarter Results
7th May 20247:00 amRNS1Q 2024 Results Conference Invitation
30th Apr 202411:21 amRNSThe 2023 Annual Report
26th Apr 202412:46 pmRNSInformation note to the shareholders
26th Apr 202412:15 pmRNSInformation note for shareholders
26th Apr 20248:16 amRNSMSCI Upgrade ESG rating to ‘BBB' from 'BB'
18th Apr 20248:23 amRNSThe completion of the sale of the subsidiary
8th Apr 20242:29 pmRNSBlock listing Interim Review
8th Apr 20241:19 pmRNSFull prepayment of state support funds
27th Mar 20247:16 amRNSFitch reaffirmed Rating; S&P revised Outlook
20th Mar 20241:57 pmRNSMaterials on the items of the agenda of the AGM
15th Mar 20249:44 amRNSConsolidated financial results for the FY 2023
12th Mar 20242:50 pmRNSAnnouncement of the AGM
4th Mar 202410:42 amRNS12M & 4Q 2023 Results Conference Call Invitation
28th Dec 202311:02 amRNSPartially prepaid KZT40bn of KKB statesupportfunds
4th Dec 20237:00 amRNSInformation note to the shareholders
4th Dec 20237:00 amRNSOn Changes in the Composition of the BoD
29th Nov 202311:08 amRNSNotice of Deep Dive Session
17th Nov 20237:00 amRNS3rd Quarter Results
10th Nov 202312:09 pmRNSSale of 100% Shares of Halyk Bank Kyrgyzstan OJSC
10th Nov 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
10th Nov 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
6th Nov 202311:20 amRNS3rd Quarter Results
2nd Nov 202312:12 pmRNSMoody’s has affirmed ratings; outlook - positive
1st Nov 20237:00 amRNSThe Extraordinary General Shareholders’ Meeting
12th Oct 202312:15 pmRNSNotice of Deep Dive Session
16th Aug 20237:58 amRNS1H & 2Q 2023 Financial Results
4th Aug 20231:14 pmRNSSustainability Report 2022
3rd Aug 20238:09 amRNS1H & 2Q 2023 Results Conference Call Invitation
9th Jun 20231:56 pmRNSThe change in the full name of the company
9th Jun 202312:26 pmRNSThe change in the full name of the company
26th May 20231:29 pmRNSOn the Election of a New Board of Directors
26th May 20231:29 pmRNSInformation note to the shareholders
26th May 20231:26 pmRNSInformation note to the shareholders
17th May 20231:44 pmRNSFully redeemed its first second bond issued
16th May 20238:47 amRNS1st Quarter Results
16th May 20238:32 amRNSCORRECTION: 1st Quarter Results
16th May 20237:04 amRNS1st Quarter Results
3rd May 202311:39 amRNS1Q 2023 Results Conference Invitation
28th Apr 202311:49 amRNSThe 2022 Annual Report of JSC Halyk Bank
24th Apr 20237:00 amRNSInformation on materials of AGM for shareholders
4th Apr 20231:00 pmRNSFitch reaffirms Halyk Bank’s Rating at 'BBB-'
31st Mar 202311:55 amEQSJSC Halyk Bank: Notice of Annual General Shareholders' Meeting
27th Mar 20231:03 pmEQSJSC Halyk Bank: S&P Global Ratings (“S&P”) has affirmed Halyk Bank’s Rating on improving banking system resilience, Outlook Stable.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.